Latest Insider Transactions at Recursion Pharmaceuticals, Inc. (RXRX)
This section provides a real-time view of insider transactions for Recursion Pharmaceuticals, Inc. (RXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RECURSION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RECURSION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
48,867
+0.38%
|
$342,069
$7.94 P/Share
|
Feb 28
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
815
+0.01%
|
$5,705
$7.97 P/Share
|
Feb 27
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
52,500
+0.41%
|
$367,500
$7.69 P/Share
|
Feb 24
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
109,118
+0.84%
|
$763,826
$7.64 P/Share
|
Feb 23
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-1.84%
|
$56,000
$7.82 P/Share
|
Feb 23
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+1.8%
|
$8,000
$1.06 P/Share
|
Feb 23
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
51,864
+0.41%
|
$363,048
$7.79 P/Share
|
Feb 22
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,941
+0.4%
|
$356,587
$7.83 P/Share
|
Feb 21
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$62,195
$7.73 P/Share
|
Feb 21
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
94,418
+0.74%
|
$660,926
$7.74 P/Share
|
Feb 17
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
63,382
+0.5%
|
$443,674
$7.71 P/Share
|
Feb 16
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
42,682
+0.34%
|
$298,774
$7.9 P/Share
|
Feb 16
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,768
-0.94%
|
$14,144
$8.42 P/Share
|
Feb 15
2023
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,258
-0.16%
|
$10,064
$8.44 P/Share
|
Feb 15
2023
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,603
-0.37%
|
$12,824
$8.44 P/Share
|
Feb 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
746
-0.39%
|
$5,968
$8.44 P/Share
|
Feb 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
7,486
-3.79%
|
$59,888
$8.33 P/Share
|
Feb 15
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,486
+3.66%
|
$14,972
$2.22 P/Share
|
Feb 15
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,346
-0.14%
|
$10,768
$8.44 P/Share
|
Feb 14
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,300
+0.05%
|
$44,100
$7.95 P/Share
|
Feb 13
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,474
+0.26%
|
$227,318
$7.97 P/Share
|
Feb 10
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,000
+0.09%
|
$77,000
$7.98 P/Share
|
Feb 07
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.81 P/Share
|
Feb 02
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.31%
|
-
|
Feb 02
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
21,500
+1.1%
|
-
|
Feb 02
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$22,500
$9.21 P/Share
|
Feb 02
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
Feb 02
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,500
-1.93%
|
$166,500
$9.22 P/Share
|
Feb 01
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,382
-0.15%
|
$11,056
$8.55 P/Share
|
Feb 01
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
417,850
+15.76%
|
-
|
Feb 01
2023
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,994
-1.55%
|
$23,952
$8.55 P/Share
|
Feb 01
2023
|
Shafique Virani Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117,090
+21.09%
|
-
|
Feb 01
2023
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,093
-0.72%
|
$24,744
$8.55 P/Share
|
Feb 01
2023
|
Tina Marriott Larson President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
226,793
+18.06%
|
-
|
Feb 01
2023
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,669
-0.33%
|
$21,352
$8.55 P/Share
|
Feb 01
2023
|
Michael Secora Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
210,163
+10.67%
|
-
|
Feb 01
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
600
+0.0%
|
$4,200
$7.97 P/Share
|
Jan 26
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-3.78%
|
$64,000
$8.07 P/Share
|
Jan 26
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.64%
|
$8,000
$1.06 P/Share
|
Jan 26
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,886
+0.06%
|
$55,202
$7.99 P/Share
|
Jan 25
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
24,526
+0.2%
|
$171,682
$7.88 P/Share
|
Jan 24
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.71 P/Share
|
Jan 17
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-12.03%
|
$90,000
$9.16 P/Share
|
Jan 17
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.67%
|
$10,000
$2.22 P/Share
|
Jan 10
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
69,518
+0.56%
|
$486,626
$7.72 P/Share
|
Jan 10
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$62,195
$7.69 P/Share
|
Jan 09
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
76,046
+0.62%
|
$532,322
$7.64 P/Share
|
Jan 06
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
68,953
+0.56%
|
$482,671
$7.41 P/Share
|
Jan 05
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.31%
|
-
|
Jan 05
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
21,500
+1.8%
|
-
|